The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy
Authors:
- M Castro-GagoMCM Castro-Gago
- 1 August 2000
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 41 (1) , 1-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effects of long‐term treatment with antiepileptic drugs on serum lipid levels in children with epilepsyNeurology, 1995
- Serum Lipid Levels During Carbamazepine MedicationArchives of Neurology, 1993
- Carbamazepine-Induced Increases in Total Serum CholesterolJournal of Clinical Psychopharmacology, 1992
- Total Cholesterol, High‐Density Lipoprotein Cholesterol, and Triglycerides in Children Receiving Antiepileptic DrugsEpilepsia, 1992
- Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbitalActa Neurologica Scandinavica, 1991
- Enhancement of peroxisomal β-oxidation in the liver of rats and mice treated with valproic acidBiochemical Pharmacology, 1985
- Heart Disease Mortality and Morbidity in Patients with EpilepsyEpilepsia, 1984
- Increase of low serum concentrations of high-density lipoprotein (HDL) cholesterol in TIA-patients treated with phenytoin.Stroke, 1983
- The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic childrenNeurology, 1983
- Effect of Phenobarbitone on Plasma Apolipoprotein B and Plasma High-Density-Lipoprotein Cholesterol in Normal SubjectsClinical Science, 1979